Synonyms: compound 28 [PMID: 24387221] | SAR-260301
Compound class:
Synthetic organic
Comment: SAR260301 (compound 28 [PMID: 24387221]) was reported in a discovery effort to optimize pyrimidone indoline amide inhibitors of PI3Kβ [2]. It is an orally bioavailable compound that is selective for PI3Kβ over other PI3 kinases.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
No information available. |
Summary of Clinical Use |
First-in-human results were published by Bédard et al. (2018) [1]. They discovered that the compound did not achieve sufficiently high enough target exposure to achieve inhibition of the PI3K pathway, an outcome which resulted in the termination of SAR260301 development. |